None listed
Conditions
Interventions
Single ingestion of unblinded liver extracts
Sponsors
Medical Corporation Hokubukai Utsukushigaoka Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1)Healthy Japanese males from 20 to 39 years of age when consented. (2)Subjects whose height is 180 cm or less and BMI is 20.0 - 24.9 kg/m2. (3)Subjects available at every designated hospital visit. (4)Subjects who agree to participate in this study and can put signature and date to informed consent form by themselves prior to the study.
Exclusion criteria
Exclusion criteria: (1)Subjects with hepatic, renal, cardiac or organ disorders, diabetes, or other serious diseases. (2)Subjects with a surgical history of digestive system (except appendicectomy). (3)Subjects with medication, or with exercise or dietary counselling by physician. (4)Subjects who cannot tolerate repetitive blood drawings. (5)Subjects who are participating in other clinical trial. (6)Subjects who have experienced a feeling of unwellness or bad physical condition by blood drawing. (7)Subjects judged as unsuitable for the study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentrations of peptides in the serum. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety evaluation including subjective symptoms, examination by a physician in charge. | — |
Countries
Japan
Contacts
Public ContactRyota Wakimoto
Medical Corporation Hokubukai Utsukushigaoka Hospital Clinical Pharmacology Center
Outcome results
None listed